Previous 10 | Next 10 |
CyrusOne (CONE) and CoreSite (COR) agreed to be acquired in deals valued at $15 billion and $10 billion, respectively. Data centers have been a significant area of growth over the last couple of decades. Ranked by colocation and data center revenues, CyrusOne and CoreSite are the ...
Pfizer (PFE +1.5%) has formally completed the acquisition of Trillium Therapeutics (TRIL). Pfizer agreed to buy Trillium in a $2.3B deal in late August. Trillium has two lead candidates, TTI-622 and TTI-621. TTI-622 is enrolling in a phase 1 trial for multiple myeloma and acute...
Trillium Therapeutics (NASDAQ:TRIL) disclosed that applicable waiting periods under the Competition Act in Canada and HSR in the U.S. expired on Monday in regards to its $2.3B sale to Pfizer (NYSE:PFE). The closing of the transaction is expected to occur on or about tomorrow, according ...
Trillium Therapeutics (NASDAQ:TRIL) rose 2.7% after a Nasdaq delisting notice indicated that the sale to Pfizer (NYSE:PFE) was tentatively scheduled to close prior to market open tomorrow. The stock is expected to be halted this evening, according to the notice. Developing sto...
Potential deal in the works, Momentive Global to be acquired by Zendesk. Zendesk, Momentive stocks fell after the deal was announced. Zendesk investors are clearly not happy with this deal and the stock received multiple downgrades after the deal was announced. For further d...
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleased to announce...
CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that i...
Big money is pouring into two disruptive segments in two of the world’s biggest industries - healthcare and energy. Both these have been undergoing continual digital disruption … But there’s more to come. In healthcare and wellness, global VC funding for dig...
Potential deal in the works Aspen Technology materializes. Two deals with Contingent Value Rights announced last week. Navios Maritime Partners completed the acquisition of Navios Maritime Acquisition Corporation. For further details see: Merger Arbitrage Mondays: Emerso...
Energy stocks could be attractive but beware of the macro-economic shifts that may affect the performance. Diversify your portfolio with a mix of sectors. Some strategies can be volatile so know yourself first to manage your emotions. For further details see: The Best Of...
News, Short Squeeze, Breakout and More Instantly...
Trillium Therapeutics Inc. Company Name:
TRIL Stock Symbol:
NASDAQ Market:
Trillium Therapeutics Inc. Website:
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributors Keith Speights and Brian Orelli explain why the news of a discontinued drug from the pharmaceutical giant hasn't shaken investors. Keith Speights: Pf...
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleased to announce...
CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that i...